新聞稿

Varian and the Cincinnati Children's/UC Health Proton Therapy Center Complete Enrollment of FAST-01, First Human Clinical Trial of FLASH Therapy for Cancer

Varian, a Siemens Healthineers company, and the Cincinnati Children's/UC Health Proton Therapy Center today announced the completion of enrollment in FAST-01 (FeAsibility Study of FLASH...

Varian Highlights Combination with Siemens Healthineers at American Society for Radiation Oncology (ASTRO) Annual Meeting

Varian, a Siemens Healthineers company, a leading provider of cancer care technologies and solutions, will demonstrate the power of intelligent cancer care to shape the future of oncology during...

Varian Receives FDA "Breakthrough Device Designation" For Embozene® Microspheres For Genicular Artery Embolization For Symptomatic Knee Osteoarthritis

Varian, a Siemens Healthineers company, announced today that the U.S. Food and Drug Administration (FDA) has granted the company Breakthrough Device Designation for its Embozene® microspheres for...

China Medical University Hospital Treats First Patient with Ethos™ Therapy in Taiwan, Expanding Access to Personalized Cancer Care

Varian, a Siemens Healthineers company, announced today that China Medical University Hospital in Central Taiwan treated its first patient with Ethos™ therapy, making it the first hospital in...

Icon Group First in World to Adopt New Multi-Disciplinary Oncology Information System from Varian

Varian, a Siemens Healthineers company, announced today that cancer patients in Australia will be the first in the world to benefit from streamlined, coordinated cancer care facilitated by an...

Varian Receives FDA "Breakthrough Device Designation" for its Cardiac Radioablation (CRA) System for Treatment of Refractory Ventricular Tachycardia (VT)

Varian, a Siemens Healthineers company, announced today that the U.S. Food and Drug Administration (FDA) has granted the company Breakthrough Device Designation for its cardiac radioablation (CRA)...

Varian and Icon Group Partner to Extend Commitment to Global Cancer Care

Varian, a Siemens Healthineers company, has signed an agreement with Australia's Icon Group to provide 30 linear accelerators and associated treatment software to help tackle the...

Siemens Healthineers completes acquisition of Varian, strengthening its position as a holistic partner in healthcare

- Transformative combination accelerates the company's impact on global healthcare and establishes a strong partner for customers and patients along the entire cancer care continuum and for many of the most threatening diseases.

- Varian…

Varian Wins Best After-Sales Service Award for Radiotherapy Products in China for Fourth Consecutive Year

Varian (NYSE: VAR) today announced it received the Best After-Sales Service Award for Radiotherapy Products in the 2020 Chinese Medical Devices Industry Data and After-Sales Service Survey for the...

Varian and Google Cloud Collaborate to Aid in the Fight Against Cancer

Varian (NYSE: VAR) today announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and...